◆英語タイトル:Genetic Signatures Ltd (GSS) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME181836PD
◆発行会社(調査会社):
GlobalData
◆発行日:2021年1月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Genetic Signatures Ltd (Genetic Signatures) formerly Human Genetic Signatures Pty Ltd, is a molecular diagnostics company. The company designs and manufactures real-time polymerase chain reaction (PCR) based products for the detection of infectious diseases under the EasyScreen brand. It offers EasyScreen multiplex real-time PCR pathogen detection kits; and MethylEasy kits for DNA bisulphite modification. Genetic Signatures’ product pathogen detection kits provide hospital and pathology laboratories with the molecular tools to screen for infectious pathogens in a rapid and high-throughput environment. The company transforms molecular diagnostics using streamlined sample processing methods linked to multiplexed real-time PCR screening assays. Genetic Signatures is headquartered in Newtown, New South Wales, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Genetic Signatures Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
List of Tables
List of Figures
Genetic Signatures Ltd Company Overview
Genetic Signatures Ltd Company Snapshot
Genetic Signatures Ltd Pipeline Products and Ongoing Clinical Trials Overview
Genetic Signatures Ltd – Pipeline Analysis Overview
Genetic Signatures Ltd – Key Facts
Genetic Signatures Ltd – Major Products and Services
Genetic Signatures Ltd Pipeline Products by Development Stage
Genetic Signatures Ltd Pipeline Products Overview
EasyScreen Assay – Atypical Pneumonia
EasyScreen Assay – Atypical Pneumonia Product Overview
EasyScreen Assay – Meningitis
EasyScreen Assay – Meningitis Product Overview
EasyScreen Assay – MRSA
EasyScreen Assay – MRSA Product Overview
EasyScreen Assay – Tuberculosis
EasyScreen Assay – Tuberculosis Product Overview
EasyScreen Enteric Protozoan Detection Kit
EasyScreen Enteric Protozoan Detection Kit Product Overview
EasyScreen Flavivirus and Alphavirus Detection Kit
EasyScreen Flavivirus and Alphavirus Detection Kit Product Overview
EasyScreen SARS-CoV-2 Detection Kit
EasyScreen SARS-CoV-2 Detection Kit Product Overview
EasyScreen Sexually Transmitted Infection / Genital Pathogen Detection Kit
EasyScreen Sexually Transmitted Infection / Genital Pathogen Detection Kit Product Overview
Genetic Signatures Ltd – Key Competitors
Genetic Signatures Ltd – Key Employees
Genetic Signatures Ltd – Locations And Subsidiaries
Head Office
Recent Developments
Genetic Signatures Ltd, Recent Developments
Nov 18, 2020: Genetic Signatures: A$2.6m R&D rebate received
Oct 28, 2019: Genetic Signatures: A$2.1m R&D rebate received
Oct 28, 2019: Genetic Signatures: Quarterly activities report – 30 September 2019
Oct 28, 2019: Genetic Signature: Non-Executive Director retirement
Jul 25, 2019: Genetic Signatures: Quarterly Activities Report – 30 June 2019
May 27, 2019: TGA registration for Respiratory Pathogen Detection Kit
Apr 29, 2019: Genetic Signatures: Quarterly activities report – 31 March 2019
Apr 10, 2019: Genetic Signatures Exhibiting at 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands
Mar 04, 2019: Genetic Signatures: Change of Company Secretary
Mar 04, 2019: Genetic Signatures: Change of Registered Address
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Genetic Signatures Ltd Pipeline Products and Ongoing Clinical Trials Overview
Genetic Signatures Ltd Pipeline Products by Equipment Type
Genetic Signatures Ltd Pipeline Products by Indication
Genetic Signatures Ltd, Key Facts
Genetic Signatures Ltd, Major Products and Services
Genetic Signatures Ltd Number of Pipeline Products by Development Stage
Genetic Signatures Ltd Pipeline Products Summary by Development Stage
EasyScreen Assay - Atypical Pneumonia - Product Status
EasyScreen Assay - Atypical Pneumonia - Product Description
EasyScreen Assay - Meningitis - Product Status
EasyScreen Assay - Meningitis - Product Description
EasyScreen Assay - MRSA - Product Status
EasyScreen Assay - MRSA - Product Description
EasyScreen Assay - Tuberculosis - Product Status
EasyScreen Assay - Tuberculosis - Product Description
EasyScreen Enteric Protozoan Detection Kit - Product Status
EasyScreen Enteric Protozoan Detection Kit - Product Description
EasyScreen Flavivirus and Alphavirus Detection Kit - Product Status
EasyScreen Flavivirus and Alphavirus Detection Kit - Product Description
EasyScreen SARS-CoV-2 Detection Kit - Product Status
EasyScreen SARS-CoV-2 Detection Kit - Product Description
EasyScreen Sexually Transmitted Infection / Genital Pathogen Detection Kit - Product Status
EasyScreen Sexually Transmitted Infection / Genital Pathogen Detection Kit - Product Description
Genetic Signatures Ltd, Key Employees
Glossary